TY  - GEN
AU  - Malucchi,S
AU  - Sala,A
AU  - Gilli,F
AU  - Bottero,R
AU  - Di Sapio,A
AU  - Capobianco,M
AU  - Bertolotto,A
TI  - Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis
SN  - 1526-632X
PY  - 2004///1220
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibody Specificity
KW  - Antiviral Agents
KW  - immunology
KW  - Cell Line, Tumor
KW  - Cytopathogenic Effect, Viral
KW  - drug effects
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Resistance
KW  - Encephalomyocarditis virus
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Incidence
KW  - Interferon beta-1a
KW  - Interferon beta-1b
KW  - Interferon-beta
KW  - antagonists & inhibitors
KW  - Isoantibodies
KW  - Life Tables
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Neutralization Tests
KW  - Prospective Studies
KW  - Severity of Illness Index
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1212/01.wnl.0000129265.73259.9e
ER  -